Trial intelligence / Profile preview

Jinqi Jiangtang Tablet for prediabetes prevention

ChiCTR-PRC-09000401Phase 4Completed

Sponsor
Tianjin University of Traditional Chinese Medicine
Start
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Jinqi Jiangtang in prediabetes (2 arms), sponsored by Tianjin University of Traditional Chinese Medicine. Primary endpoints: Evaluation of efficacy on diabetes conversion and SF-36 and prediabetes patient-reported outcome score. Started Dec 2008; status: completed.

02

Drugs

Jinqi Jiangtang
03

Conditions

prediabetes

Beyond the preview

Go deeper on ChiCTR-PRC-09000401.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-PRC-09000401.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call